Amount of royalty-free Amount of Intangible Asset Representing Royalty Free Amount of intangible asset representing rroyalty free. Intangible Assets (Details) [Table] License [Member] Licenses [Member] Licensing payment Payment Of Licensing Payment Represent the amount of licensing payment. Total cumulative payment Total Cumulative Payment Represent the amount of total cumulative payment. Unpaid royalties Unpaid Royalties Amount of unpaid royalities. Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Accrued royalty liability Accrued Royalties Amortization expense Intangible Asset, Finite-Lived, Amortization Expense Intangible Asset, Finite-Lived, Class [Axis] Intangible Assets [Line Items] Intangible Asset, Finite-Lived, Class [Domain] Intangible Assets [Abstract] Estimated useful life Intangible Asset, Finite-Lived, Useful Life Royalty payments Royalty Expense Accumulated amortization Intangible Asset, Finite-Lived, Accumulated Amortization Gross amount Intangible Asset, Finite-Lived, before Accumulated Amortization Intangible assets, net Intangible assets, net Intangible Asset, Finite-Lived, after Accumulated Amortization Stockholders’ Equity (Details) [Table] Sale of Stock [Axis] Sale of Stock [Domain] IPO [Member] IPO [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] CAD Warrants [Member] CADWarrants Member Debentures Warrants Liability [Member] Debentures Warrants Liability Member IPO Agent Warrants [Member] IPOAgent Warrants Member Stockholders’ Equity [Line Items] Schedule of Warrants Outstanding and Exercisable [Line Items] Derivative liabilities Derivative Liability Change in the fair value of the CAD Warrants Gain In The Fair Value Of The CADWarrants Amount of gain in the fair value of the cad warrants. Change in fair value of the IPO agent warrants liability Change In Fair Value Of IPOAgent Warrants Liability The amount of change in fair value of IPO agent warrants liability. Stock price per share (in Dollars per share) Sale Of Stock Price Per Shares The amount of sale of stock price per shares. Number of trading days Nunber Of Trading Days Nunber of trading days. Consecutive-trading-day Consecutivetradingdays Consecutive-trading-day, Performance period of shares (in Shares) Number Of Earned Shares The number of earned shares. Threshold price per share (in Dollars per share) Thresold Price Per Share Thresold price per share. Price per share (in Dollars per share) Sale of Stock, Price Per Share Grant-date fair value Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Granted shares (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Granted per value (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Grant-date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Stock-based compensation expense Stock-based compensation expense for the period January 1, 2026 to April 30, 2026 Share-Based Payment Arrangement, Expense Financial Instruments [Domain] Equity Option [Member] Equity Option [Member] Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Common Stock [Member] Warrants to purchase shares (in Shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price per share (in Dollars per share) Exercise Price Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants liabilities Warrant liabilities Warrants and Rights Outstanding Change in fair value of the initial and additional Gain In The Fair Value Of The Initial Additional Warrants Amount of gain in fair value of the initial additional warrants. Public offering of common stock issued (in Shares) Stock Issued During Period, Shares, Other Warrant exercise price (in Dollars per share) Warrant, Exercise Price, Decrease Warrants outstanding (in Shares) Shares Exercisable Class of Warrant or Right, Outstanding Outstanding CAD options Options exercised (in Shares) Number of Options, Exercised Outstanding stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period CAD Options [Member] CADOptions Member CAD options liability Fair Value of CAD Options Liability mount of cad option liability. Weighted average common stock outstanding Weighted average shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Dilutive effect of CAD options Dilutive Effect Of Common Stock Warrants Number of shares dilutive effect of common stock warrants. Weighted average dilutive common stock Weighted average outstanding stock, diluted Weighted Average Number of Shares Outstanding, Diluted Foreign currency forward contract Foreign Currency Contracts, Liability, Fair Value Disclosure Foreign currency collar contracts notional amount Foreign Currency Collar Contracts Notional Amount Foreign currency collar contracts notional amount. Segment Information [Abstract] Weighted Average Exercise Price, Issued Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Number of Warrants, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Weighted Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Aggregate Intrinsic Value, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Number of Options, Cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Weighted Average Exercise Price, Cancelled Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Schedule of Options Liability [Abstract] Fair value of CAD Option liability at June 30, 2026 Option liability Fair value of CAD Option liability at December 31, 2025 Option Liabilities Noncurrent The amount of option liabilities. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Common Stock options [Member] Common Stock Options Member ACI Canada legacy performance options [Member] ACICanada Legacy Performance Options Member Schedule of Potentially Dilutive Outstanding Securities [Line Items] Total anti-dilutive features Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Foreign Currency Contracts [Table] Currency [Axis] All Currencies [Domain] EUR [Member] Euro Member Countries, Euro Foreign Currency Contracts [Line Items] Additional Debenture Warrants [Member] Additional Debenture Warrants Member Warrant [Member] Warrants [Member] Warrant [Member] Schedule of Common Stock Option Activity [Line Items] Reclassification to equity following April 30, 2026 modification Reclassification to Equity Reclassification to equity amount. Number of Options, Reclassified to Equity Number of Options Reclassified to Equity Number of options reclassified to equity. Weighted Average Exercise Price Reclassified to Equity Weighted average exercise price reclassified to equity. Schedule Of Weighted Average Assumptions Were Used In The Black Scholes Option Pricing Model Abstract Initial and Additional Debenture Warrants [Member] Initial And Additional Debenture Warrant Member Common Share Options [Member] Common Share Options Member Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Weighted average grant-date fair value per option (in Dollars per share) Share Price Options Price of a single share of a number of saleable stocks options of a company. Weighted average fair value per warrant (in Dollars per share) Share Price Schedule of Common Stock Options Activity [Abstract] Stockholders’ Equity - Schedule of Common Stock Options Activity (Details) [Table] Aggregate Intrinsic Value, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Number of Options, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Schedule of Presents Revenues from Customers [Table] Segment Information - Schedule of Presents Revenues from Customers (Details) [Table] Geographical [Axis] Current liabilities Liabilities, Current [Abstract] Document Information [Line Items] Document Type Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Common Stock, Shares Outstanding Title of 12(b) Security Security Exchange Name Statement [Line Items] Revenue Revenues [Abstract] Total revenue Revenues Operating Expenses Operating expenses Operating Expenses [Abstract] Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Current Fiscal Year End Date Schedule of Significant Segment Expenses [Abstract] Research and development: Research and Development [Abstract] Total research and development Research and development Research and Development Expense Statement of Financial Position [Abstract] Current assets Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalent Restricted cash Restricted Cash, Current Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accounts payable and accrued liabilities Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Current deferred income Contract with Customer, Liability, Current Total current liabilities Liabilities, Current Deferred income Contract with Customer, Liability, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Total liabilities and stockholders’ equity Liabilities and Equity Statement [Table] Class of Stock [Axis] Class of Stock [Domain] Class B Preferred Stock Preferred Class B [Member] Preferred stock, shares outstanding (in Shares) Preferred Stock, Shares Outstanding Income Statement [Abstract] Other current liabilities Other Liabilities, Current Loss on foreign currency contracts Change in fair value for foreign currency contracts Gain (Loss), Foreign Currency Transaction, before Tax Warrants exercised (in Shares) Stock Issued During Period Shares Warrants Exercisedi Warrant exercised. Warrants exercised Stock Issued During Period Value Warrants Exercised warrant exercised amount. Reclassification of CAD options Adjustment to Additional Paid in capital Reclassification of CAD Options Adjustment to additional paid in capital reclassification of cad options. Proceeds from exercises of warrants Proceeds from Warrant Exercises Reclassification of CAD option liability to equity Reclassification of Cad Option Liability to Equity Reclassification of cad option liability to equity. Cost of Revenues Cost of Revenue [Abstract] Total cost of revenues Cost of Revenue, Total Cost of product sales, excluding amortization of intangible assets Cost of Product Sales Excluding Amortization of Intangible Assets [Member] Cost of licensing revenue Cost of Licensing Revenue [Member] Amortization of intangible assets Amortization of Intangible Assets [Member] Gross Profit Gross Profit Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders’ equity Balance Balance Equity, Attributable to Parent Common stock, par value (in Dollars per share) Common Stock, No Par Value Common stock, shares authorized Common Stock, Shares Authorized, Unlimited [Fixed List] Common stock, shares issued (in Shares) Common Stock, Shares, Issued Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Preferred stock, par value (in Dollars per share) Preferred Stock, No Par Value Preferred stock, shares authorized Preferred Stock, Shares Authorized, Unlimited [Fixed List] Preferred stock, shares issued (in Shares) Preferred Stock, Shares Issued Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Deferred income Increase (Decrease) in Contract with Customer, Liability Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash flows used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Acquisition of equipment Payments to Acquire Property, Plant, and Equipment Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Reallocation of fair value of share options upon exercise Reallocation Of Fair Value Of Share Options Upon Exercises Reallocation of fair value of share options upon exercise. Nature of Operations [Abstract] NATURE OF OPERATIONS Nature of Operations [Text Block] Revisions to Previously Issued Condensed Consolidated Financial Statements and Financial Information [Abstract] Inventory Total Inventory, Net Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Total assets Assets Preferred Stock Preferred Stock [Member] Options exercised Stock Issued During Period, Value, Stock Options Exercised Stock-based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Net loss Net loss and comprehensive loss Net loss and comprehensive loss Balance (in Shares) Balance (in Shares) Shares, Outstanding China [Member] CHINA Segment Reporting [Table] Product and Service [Axis] Product and Service [Domain] Product, net [Member] Product, net Product Net Member Licensing [Member] Licensing License [Member] Segment Reporting [Line Items] Total selling, general and administrative expenses Selling, general and administrative expenses Selling, General and Administrative Expense Total operating expenses Total operating expenses Total operating expenses Operating Expenses Loss from operations Loss from operations Net operating loss Operating Income (Loss) Net loss per share, basic Earnings Per Share, Basic Additional Paid-In Capital Additional Paid in Capital [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Accumulated Deficit Accumulated Deficit [Member] Retained Earnings [Member] Statement of Cash Flows [Abstract] Cash flows used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Accrued expenditures for government grant Government Assistance, Operating Expense, Decrease (Increase) Change in fair value of bonus rights liability Change In Fair Value Of Bonus Rights Liability Change in fair value of bonus rights liability. Loss on disposal of equipment Gain (Loss) on Disposition of Property Plant Equipment Stock-based compensation – equity-classified options Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Revision of Prior Period [Axis] As Reported [Member] Previously Reported [Member] Adjustment [Member] Revision of Prior Period, Adjustment [Member] As Revised [Member] As Revised Member Revision of Prior Period [Domain] Financial Instrument [Axis] Manufacturing deposit Manufacturing Deposit Amount of manufacturing deposit. Non-Rule 10b5-1 Arrangement Modified Non Rule10b51 Arrangement Modified Flag Non-Rule 10b5-1 Arrangement Modified [Flag]. Schedule of Condensed Consolidated Statement of Stockholders’ Equity Schedule of Stockholders Equity [Table Text Block] Schedule of Condensed Consolidated Statement of Cash Flows Condensed Cash Flow Statement [Table Text Block] Inventory [Abstract] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] REVISIONS TO PREVIOUSLY ISSUED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL INFORMATION Condensed Financial Information of Parent Company Only Disclosure [Text Block] INTANGIBLE ASSETS Intangible Asset [Text Block] Work in progress Inventory, Work in Process, Gross Finished goods Inventory, Finished Goods, Gross Others Other Receivables, Net, Current Other Balance Sheet Components [Abstract] Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of Warrants Outstanding and Exercisable Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Weighted Average Assumptions were used in the Black-Scholes Option-Pricing Model Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Common Stock Options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Options Liability Schedule Of Options Liability Table Text Block Net Loss Per Share [Abstract] Schedule of Reconciles Net Loss and the Weighted Average Shares Outstanding Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule Of Condensed Consolidated Statement Of Operations And Comprehensive Loss Abstract Condensed Statement of Comprehensive Income [Table] Total other income (expenses) Total other income (expenses) Nonoperating Income (Expense) Net loss per share, diluted Net loss per share, diluted Earnings Per Share, Diluted Schedule Of Condensed Consolidated Statement Of Stockholders Equity Abstract Significant Accounting Policies [Abstract] Significant Accounting Policies (Details) [Table] Accrued Clinical Research Costs Accrued clinical research costs. Accrued gross-to-net discounts Accrued Grosstonet Discounts Accrued gross-to-net discounts. Schedule of Accounts Payable and Accrued Expenses [Abstract] Accounts payable Accounts Payable, Current Accrued inventory costs Accrued Employee Benefits, Current Accrued payroll and bonuses Accrued Payroll Taxes, Current Other accrued liabilities Other Accrued Liabilities, Current Decrease in fair value Decrease In Fair Value of Share Based Compensation Shares decrease in share based compensation. Stockholders’ Equity [Abstract] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Schedule of Intangible Assets [Abstract] Schedule of Estimated Future Annual Amortization Expense Related to Intangible Assets [Abstract] 2026 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Thereafter Intangible Asset, Finite-Lived, Estimated Amortization Expense, after Year Five Schedule Of Warrant Activity Abstract Weighted Average Exercise Price, Expired Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Grant Date Fair Value Weighted Average Exercise Price (as converted), Expired. Schedule of Reconciles Net Loss and the Weighted Average Shares Outstanding [Abstract] Numerator, diluted: Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract] Adjustment for gain in fair value of CAD option liabilities Adjustment For Gain In Fair Value Of Warrant Liabilitiesin Dollars The amount adjustment for gain in fair value of warrant liabilities. Schedule Of Potentially Dilutive Common Shares Related To Outstanding Securities Abstract Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Foreign Currency Contracts [Abstract] Operating segment Number of Operating Segments Number of reportable segment Number of Reportable Segments Disclosure Text Block Supplement [Abstract] Initial Debenture Warrants [Member] Initial Debenture Warrants Member Stockholders’ Equity - Schedule of Warrants Outstanding and Exercisable (Details) [Table] Private placements [Member] Private Placements Member Prefunded warrants [Member] Prefunded Warrants Member CAD Warrants [Member] Exercise Price Six Point Eighty Six CAD Nine Point Seventy Five [Member] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Weighted Average Assumptions were used in the Black-Scholes Option-Pricing Model [Line Items] Number of Warrants, Balance Number of Warrants, Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted Average Exercise Price, Balance Weighted Average Exercise Price, Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Number of Warrants, Issued Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Options, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Weighted Average Remaining Contractual Life (Years), Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Number of Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Adjusted numerator, diluted Net Income (Loss) Available to Common Stockholders, Diluted Denominator, diluted: Weighted Average Number of Shares Outstanding, Basic [Abstract] Weighted Average Exercise Price, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Liability-Classified CAD Options [Member] Liability Classified CADOptions Member CAD Warrants [Member] exercise Price Six Point Eighty Six To CAD Nine Point Seventy Five [Member] Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years), Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Weighted Average Exercise Price, Exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Priceas Converted Exercised Represent the amount of weighted average exercise price (as converted), exercised. Number of Warrants, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Stockholders’ Equity - Schedule of Weighted Average Assumptions were used in the Black-Scholes Option-Pricing Model (Details) [Table] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Domain] Monte Carlo [Member] Monte Carlo Member Stockholders’ Equity - Schedule of Warrant Activity (Details) [Table] Expiry Date Class Of Right Of Warrant Expiry Date class of right of warrant expiry date. Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Cash flows provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Proceeds from exercises of options Proceeds from Stock Options Exercised Repayment of promissory notes Repayments of Notes Payable Proceeds received from restricted government grant Proceeds Received From Restricted Government Grant Proceeds received from restricted government grant. Amounts paid from restricted government grant funds Amounts Paid From Restricted Government Grant Funds Amounts paid from restricted government grant funds. Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Change in cash, cash equivalents, and restricted cash during the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Cash, cash equivalents, and restricted cash beginning of period Cash, cash equivalents, and restricted cash end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Supplemental Disclosure Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Supplemental non-cash disclosures Noncash Investing and Financing Items [Abstract] Selling, general and administrative expenses: Selling, General and Administrative Expense [Abstract] Geographical [Domain] United States [Member] UNITED STATES Schedule of Currently Operates in a Single Reportable Operating Segment [Line Items] Total revenue Revenue from Contract with Customer, Including Assessed Tax Schedule of Presents Revenues Ffrom Customers [Abstract] Adjusted net loss, diluted Net Income (Loss) Attributable to Parent, Diluted, Total Change in Fair Value of Warrant Liabilities Represent the amount of change in fair value of warrant liabilities. Acquisition of intangible asset Payments to Acquire Intangible Assets Clinical Studies [Member] Consulting Fees [Member] Segments [Axis] Segments [Domain] Segment Expenses [Member] Employee Costs [Member] Grant Expenses [Member] Stock-Based Compensation [Member] Other [Member] Commercial Manufacturing [Member] Commercial Operations [Member] Depreciation [Member] Sales and Marketing [Member] General and Administrative [Member] Segment description Segment Reporting, Expense Information Used by CODM, Description Other income (expenses) Nonoperating Income (Expense) [Abstract] Interest income, net Investment Income, Interest Grant income Government Assistance, Nonoperating Income, Increase (Decrease) Statement of Stockholders' Equity [Abstract] Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Current Reporting Status Entity Filer Category Entity File Number Entity Shell Company Entity Emerging Growth Company Entity Ex Transition Period Entity Small Business Cover [Abstract] Document Information [Table] Document Quarterly Report Document Transition Report Entity Address, Address Line One Trading Symbol Loss on change in fair value of warrant liabilities Gain (Loss) of Warrant Liabilities Amount of gain loss of warrant liabilities. Other income (expenses) Other Nonoperating Income (Expense) Entity Interactive Data Current Stockholders’ equity Equity, Attributable to Parent [Abstract] Common stock, no par value, unlimited shares authorized, 21,774,104 and 21,742,104 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Class B preferred stock, no par value, unlimited shares authorized, 316,655 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively Preferred Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Stock-based compensation – liability-classified CAD options Stockbased Compensation Liabilityclassified CADOptions Represent the amount of stock-based compensation – liability-classified CAD options. Changes in non-cash operating working capital items: Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Amendment Flag Significant Accounting Policies [Line Items] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] INVENTORY Inventory Disclosure [Text Block] OTHER BALANCE SHEET COMPONENTS Supplemental Balance Sheet Disclosures [Text Block] SEGMENT INFORMATION Segment Reporting [Text Block] Subsequent Events [Abstract] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Condensed Consolidated Statement of Operations and Comprehensive Loss Condensed Statement of Comprehensive Income [Table Text Block] Schedule of Intangible Assets Intangible Asset, Finite-Lived [Table Text Block] Schedule of Estimated Future Annual Amortization Expense Related to Intangible Assets Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Schedule of Warrant Activity Schedule Of Activity For The Warrants Table Text Block Tabular disclosure of activity for the warrants. Schedule of Potentially Dilutive Common Shares Related to Outstanding Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Presents Revenues from Customers Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table Text Block] Schedule of Condensed Consolidated Statement of Operations and Comprehensive Loss [Line Items] Research and development Other Research and Development Expense General and administrative expenses Other General and Administrative Expense Revisions to Previously Issued Condensed Consolidated Financial Statements and Financial Information - Schedule of Condensed Consolidated Statement of Stockholders’ Equity (Details) [Table] STOCKHOLDERS’ EQUITY Shareholders' Equity and Share-Based Payments [Text Block] FOREIGN CURRENCY CONTRACTS Foreign Currency Disclosure [Text Block] NET LOSS PER SHARETOCK Earnings Per Share [Text Block] Use of Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] Liability-Based Awards Liability Based Awards Policy Text Block Disclosure of accounting policy for liability-based awards. SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Liquidity Liquidity Policy Text Block Liquidity policy text block. Rule 10b5-1 Arrangement Modified Rule10b51 Arrangement Modified Flag Rule 10b5-1 Arrangement Modified [Flag]. Schedule of Significant Segment Expenses Schedule of Significant Segment Expenses [Table Text Block] Significant Segment Expenses. Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items] Condensed Cash Flow Statement [Table] Schedule of Condensed Consolidated Statement of Cash Flows [Line Items] Schedule of Accounts Payable and Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Prepaid Expenses and Other Current Assets [Abstract] Prepaid insurance and other expenses Prepaid Insurance Prepaid FDA user fees Prepaid FDAUser Fees Prepaid FDA user fees. Prepaid legal expenses Other Prepaid Expense, Current Deferred ATM offering costs Deferred Offering Costs Schedule Of Condensed Consolidated Statement Of Cash Flows Abstract Schedule of Inventory [Abstract] Raw materials Inventory, Raw Materials, Gross Chief Executive Officer